2017
Using ePrognosis to estimate 2-year all-cause mortality in older women with breast cancer: Cancer and Leukemia Group B (CALGB) 49907 and 369901 (Alliance A151503)
Kimmick GG, Major B, Clapp J, Sloan J, Pitcher B, Ballman K, Barginear M, Freedman RA, Artz A, Klepin HD, Lafky JM, Hopkins J, Winer E, Hudis C, Muss H, Cohen H, Jatoi A, Hurria A, Mandelblatt J. Using ePrognosis to estimate 2-year all-cause mortality in older women with breast cancer: Cancer and Leukemia Group B (CALGB) 49907 and 369901 (Alliance A151503). Breast Cancer Research And Treatment 2017, 163: 391-398. PMID: 28283904, PMCID: PMC5508575, DOI: 10.1007/s10549-017-4188-6.Peer-Reviewed Original ResearchConceptsMortality rateBreast cancerNon-cancer mortality risksOlder breast cancer patientsStage I-IIA diseaseTwo-year mortality rateAdjuvant therapy decisionsResultsPatients' mean ageCooperative group studiesKaplan-Meier methodOverall survival estimatesBreast cancer patientsAvailable clinical informationCommunity-dwelling eldersObserved mortality rateBreast Cancer StudyAdjuvant therapyCause mortalityMost patientsOlder patientsBetter prognosisWorse prognosisPoor prognosisTrial populationMean age
2014
Adjuvant Chemotherapy in Breast Cancer
Lim E, Goel S, Winer E. Adjuvant Chemotherapy in Breast Cancer. 2014, 335-351. DOI: 10.1007/978-1-4939-1145-5_23.Peer-Reviewed Original ResearchAdjuvant chemotherapyAdjuvant chemotherapy regimenAdjuvant systemic therapyAdjuvant combination chemotherapyBreast cancer recurrenceYears of ageChemotherapy regimenPrognostic determinantsSystemic therapyCombination chemotherapyClinicians' estimationTumor stagePatient prognosisPatient outcomesCancer recurrenceBreast cancerMortality rateClinical practiceTumor biologyClinical settingChemotherapyBiological rationalePrognosisRecurrenceSignificant reduction
2009
Clinical Cancer Advances 2009: Major Research Advances in Cancer Treatment, Prevention, and Screening—A Report From the American Society of Clinical Oncology
Petrelli NJ, Winer EP, Brahmer J, Dubey S, Smith S, Thomas C, Vahdat LT, Obel J, Vogelzang N, Markman M, Sweetenham JW, Pfister D, Kris MG, Schuchter LM, Sawaya R, Raghavan D, Ganz PA, Kramer B. Clinical Cancer Advances 2009: Major Research Advances in Cancer Treatment, Prevention, and Screening—A Report From the American Society of Clinical Oncology. Journal Of Clinical Oncology 2009, 27: 6052-6069. PMID: 19901123, DOI: 10.1200/jco.2009.26.6171.Peer-Reviewed Original ResearchMeSH KeywordsBiomedical ResearchEvidence-Based MedicineFemaleFinancing, GovernmentHealth PolicyHumansMaleMass ScreeningMedical OncologyNeoplasmsPractice Guidelines as TopicPredictive Value of TestsQuality of Health CareQuality of LifeResearch Support as TopicSocieties, MedicalTime FactorsTreatment OutcomeUnited StatesConceptsClinical cancer researchClinical OncologyAmerican SocietyCancer treatmentScreening—A ReportPatients 40 yearsThird of patientsCancer researchCourse of diseaseCancer mortality ratesHealth care accessClinical research programNational Cancer InstituteHigh-quality careClinical research projectsSite of originClinical research enterpriseHigh-quality treatmentPatients' qualityPersonalized cancer medicineASCO'S PRESIDENTCare accessCancer InstituteMortality ratePatient care